£149.38

Springer DNA Methylation, Epigenetics and Metastasis: 7 (Cancer Metastasis - Biology and Treatment, 7)

Price data checked 1 day ago

View at Amazon

Price History & Forecast

Last 90 days • 90 data points

Historical
Generating forecast...
£149.64 £138.49 £140.92 £143.35 £145.79 £148.22 £150.65 11 February 2026 05 March 2026 27 March 2026 18 April 2026 11 May 2026

Price Distribution

Price distribution over 90 days • 2 price levels

Days at Price
Current Price
15 days 75 days · current 0 19 38 56 75 £140 £149 Days at Price

Price Analysis

Most common price: £149 (75 days, 83.3%)

Price range: £140 - £149

Price levels: 2 different prices over 90 days

Description

Most of the cancer patients die because the tumoral cells do not "stick" in the original site, but instead detach, invade and disseminate throughout the bloodstream to distal sites, where these transformed cells start to proliferate and destroy again. In the last ten years, researchers have identified a number of important genes involved in these processes, including cadherins, laminins, heparan sulfates, inhibitors of proteases and angiogenesis and many others. The puzzling problem was that few genetic alterations in these genes had been described in human tumors, despite the common finding of down-regulation. CpG island hypermethylation-associated silencing has come to the rescue of several of these genes and has situated them in the forefront of the current cancer research. However epigenetic silencing is also much more than aberrant DNA methylation, a whole set of histone modifiers and chromatin remodelling factors "conspire" to maintain the repression of these tumor/metastasis suppressor genes. DNA demethylating agents and inhibitors of histone deacetylases are the first generation of epigenetic drugs to beat them. In this book, the current directions in the epigenetics of cancer progression and metastasis are comprehensively described. It is now the turn of the reader to take care of the future. Dr Manel Esteller, Director, Cancer Epigenetics Laboratory, Spanish National Cancer Centre (CNIO) mesteller@cnio.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
22 October 2010
Listed Since
20 September 2010

Barcode

No barcode data available

Similar Products You Might Like

Signal Transduction in Cancer Metastasis: 15 (Cancer Metastasis - Biology and Treatment, 15)
85% match

Signal Transduction in Cancer Metastasis: 15 (Cancer Metastasis - Biology and Treatment, 15)

Springer

£113.77 11 May 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
83% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£80.64 11 May 2026
Lymphangiogenesis in Cancer Metastasis: 13 (Cancer Metastasis - Biology and Treatment, 13)
83% match

Lymphangiogenesis in Cancer Metastasis: 13 (Cancer Metastasis - Biology and Treatment, 13)

Springer

£113.76 11 May 2026
DNA Repair of Cancer Stem Cells
82% match

DNA Repair of Cancer Stem Cells

Springer

£108.75 11 May 2026
Selected Aspects of Cancer Progression: Metastasis, Apoptosis and Immune Response: 11 (Cancer Growth and Progression, 11)
81% match

Selected Aspects of Cancer Progression: Metastasis, Apoptosis and Immune Response: 11 (Cancer Growth and Progression, 11)

Springer

£113.76 11 May 2026
Cell Motility in Cancer Invasion and Metastasis: 8 (Cancer Metastasis - Biology and Treatment, 8)
81% match

Cell Motility in Cancer Invasion and Metastasis: 8 (Cancer Metastasis - Biology and Treatment, 8)

Springer

£150.29 11 May 2026
Risk and Progression Factors in Carcinogenesis: 143 (Recent Results in Cancer Research, 143)
81% match

Risk and Progression Factors in Carcinogenesis: 143 (Recent Results in Cancer Research, 143)

Springer

£77.79 11 May 2026
Proteases and Their Inhibitors in Cancer Metastasis: 4 (Cancer Metastasis - Biology and Treatment, 4)
81% match

Proteases and Their Inhibitors in Cancer Metastasis: 4 (Cancer Metastasis - Biology and Treatment, 4)

Springer

£108.95 11 May 2026
Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development (Current Clinical Oncology)
80% match

Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development (Current Clinical Oncology)

Springer

£71.91 04 May 2026
Cell Signaling & Molecular Targets in Cancer
80% match

Cell Signaling & Molecular Targets in Cancer

Springer

£107.98 04 May 2026
Cell Signaling & Molecular Targets in Cancer
80% match

Cell Signaling & Molecular Targets in Cancer

Springer

£43.99 04 May 2026
Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)
80% match

Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)

£65.70 04 May 2026
Gene Regulation and Therapeutics for Cancer
79% match

Gene Regulation and Therapeutics for Cancer

CRC Press

£69.94 11 May 2026
MicroRNAs in Cancer Translational Research
79% match

MicroRNAs in Cancer Translational Research

Springer

£129.92 10 May 2026
The Heterogeneity of Cancer Metabolism: 1311 (Advances in Experimental Medicine and Biology, 1311)
79% match

The Heterogeneity of Cancer Metabolism: 1311 (Advances in Experimental Medicine and Biology, 1311)

Springer

£40.29 04 May 2026
Morphine and Metastasis
79% match

Morphine and Metastasis

Springer

£74.00 11 May 2026
Tumor Biology: Regulation of Cell Growth, Differentiation and Genetics in Cancer: 99 (Nato ASI Subseries H:, 99)
79% match

Tumor Biology: Regulation of Cell Growth, Differentiation and Genetics in Cancer: 99 (Nato ASI Subseries H:, 99)

Springer

£109.61 11 May 2026
Epigenetic Mechanisms in Breast Cancer Therapy and Resistance (Advances in Experimental Medicine and Biology, 1465)
79% match

Epigenetic Mechanisms in Breast Cancer Therapy and Resistance (Advances in Experimental Medicine and Biology, 1465)

Springer

£127.59 04 May 2026
Oral Cancer: Diagnosis and Therapy
79% match

Oral Cancer: Diagnosis and Therapy

Springer

£94.43 11 May 2026
78% match

Molecular Mechanisms of Cancer Resistance: Emerging Technologies and Therapeutic Strategies (Novel approaches to overcome cancer resistance to conventional therapies)

Academic Press

£153.99 11 May 2026
Apoptosis in Carcinogenesis and Chemotherapy: Apoptosis in cancer
78% match

Apoptosis in Carcinogenesis and Chemotherapy: Apoptosis in cancer

Springer

£145.38 11 May 2026
Frontiers in Cancer Research: Evolutionary Foundations, Revolutionary Directions
78% match

Frontiers in Cancer Research: Evolutionary Foundations, Revolutionary Directions

Springer

£112.41 04 May 2026
Cancer Gene Therapy by Viral and Non-viral Vectors: 4 (Translational Oncology)
78% match

Cancer Gene Therapy by Viral and Non-viral Vectors: 4 (Translational Oncology)

Wiley

£105.71 04 May 2026
Nano-Oncologicals: New Targeting and Delivery Approaches (Advances in Delivery Science and Technology)
78% match

Nano-Oncologicals: New Targeting and Delivery Approaches (Advances in Delivery Science and Technology)

Springer

£114.71 11 May 2026